Keck researchers aim to enroll 500 participants in phase 3 of the clinical trial of the experimental vaccine AZD1222.
Author: Apryl Lundsten
Pandemic Forecasting: Looking Ahead
USC Viterbi researchers answer questions about their unique modeling tool and share advice for future forecasters.
Keck Enrolling Volunteers for Phase 3 of COVID-19 Clinical Drug Trial
Keck researchers aim to enroll 500 participants in phase 3 of the clinical trial of the experimental vaccine AZD1222.
Pandemic Forecasting: Looking Ahead
USC Viterbi researchers answer questions about their unique modeling tool and share advice for future forecasters.
Popular Festival Goes Online
USC hosted an online physics and astronomy festival for eighth graders unable to make their annual field trip to USC.
USC Scientists Identify the Order of COVID-19 Symptoms
Knowing which symptoms appear first will help doctors identify COVID-19 patients sooner and make better treatment decisions.
A Resource for Local Businesses During the Pandemic
A new task force, comprised of USC Gould School of Law students, is helping local small businesses navigate the changing health and safety guidelines about COVID-19.
A New Partnership to Help L.A.’s Homeless Community
MoceanLab has partnered with the Keck School to provide low-emission hybrid vehicles for Keck’s Street Medicine Team to reach and treat L.A.’s homeless during the pandemic.
Helping Neighbors in Need
The USC Community Outreach Fund has awarded more than $81,000 to community programs supporting local families impacted by COVID-19.
A “SAFE-T” Net
The USC Telehealth SAFE-T Program provides pro bono telehealth counseling services to underserved populations during the pandemic.